Dianthus Therapeutics | MGTA - Créanciers Commerciaux





Créanciers Commerciaux Changement Date
Akebia Therapeutics USD 8.39M 12.8M 2026-03
Alaunos Therapeutics USD 400K 213K 2026-03
Avita Medical AUD 8.96M 1.69M 2025-12
Celltrion KRW 78.68B 25.51B 2025-12
Cspc Pharmaceutical CNY 2.32B 236.83M 2025-12
Deva Holding AS TRY 809.81M 105.88M 2023-09
Dianthus Therapeutics USD 5.27M 4.45M 2026-03
Divis Laboratories Ltd INR 12.11B 1.71B 2026-03
IQVIA Holdings USD 3.64B 112M 2026-03
Kangmei Pharma CNY 2.46B 153.5M 2026-03
Knight Therapeutics CAD 125.76M 7.63M 2025-12
Laboratorios Farma EUR 107.59M 341K 2023-12
Malin Corporation EUR 700K 200K 2024-12
Medical Developments International AUD 4.31M 2.18M 2025-12
Moderna USD 161M 156M 2026-03
Neuren Pharmaceuticals AUD 2.4M 4.26M 2025-12
Organigram Holdings CAD 71.08M 18.17M 2025-12
Organon & Co USD 983M 31M 2026-03
Ovoca Bio EUR 186K 23K 2025-06
Pharma Mar EUR 43.83M 10.51M 2026-03
Qiagen NV USD 72.66M 2.11M 2025-12
Revvity USD 169.68M 15.78M 2026-03
Sartorius EUR 345.3M 2.2M 2026-03
Sino Biopharmaceutical CNY 2.82B 1.32B 2025-06
Tectonic Therapeutic USD 2.55M 1.46M 2026-03
Tilray USD 114.5M 3.69M 2025-09
Viatris USD 1.2B 93.9M 2026-03
Xeris Pharmaceuticals USD 11.47M 8.39M 2026-03
Zealand Pharma A/S 346.6M 102.71M 2025-12
Zz Pientze Pharmaceu CNY 457.05M 59.09M 2026-03